AssetMark’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.9K Buy
696
+49
+8% +$1.29K ﹤0.01% 2294
2026
Q2
$16.4K Buy
647
+9
+1% +$205 ﹤0.01% 2266
2026
Q1
$13.6K Buy
638
+191
+43% +$3.98K ﹤0.01% 2202
2025
Q4
$9.6K Buy
447
+277
+163% +$5.68K ﹤0.01% 2230
2025
Q3
$2.85K Buy
+170
New +$2.55K ﹤0.01% 2529
2020
Q1
– Sell
-75
Closed -$2K – 1471
2019
Q4
$2K Buy
+75
New +$1.88K ﹤0.01% 1245
2018
Q1
– Sell
-26
Closed -$1K – 1740
2017
Q4
$1K Buy
26
+17
+189% +$802 ﹤0.01% 1647
2017
Q3
$0 Buy
+9
New +$428 ﹤0.01% 1555
2017
Q1
– Sell
-1
Closed – – 1369
2016
Q4
$0 Sell
1
-55
-98% -$3.58K ﹤0.01% 1330
2016
Q3
$4K Buy
56
+5
+10% +$342 ﹤0.01% 1064
2016
Q2
$4K Sell
51
-33
-39% -$2.27K ﹤0.01% 1041
2016
Q1
$5K Buy
84
+34
+68% +$2.26K ﹤0.01% 970
2015
Q4
$4K Buy
+50
New +$3.7K ﹤0.01% 1002

Other funds holding MD

AssetMark's MD Position: Q3 2026 in Review

AssetMark increased its Pediatrix Medical (MD) stake by 7.6% in Q3 2026, buying an estimated $1.29K and bringing the position to 696 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2294.

AssetMark first reported a position in MD in Q4 2015 and has held it in 13 quarters since. 253 funds tracked by Wall St. Rank hold MD as of Q3 2026.

  • AssetMark held 696 shares of Pediatrix Medical worth $17.9K as of Q3 2026.
  • AssetMark bought 49 Pediatrix Medical shares in Q3 2026, an estimated $1.29K.
  • Pediatrix Medical made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2294 holding.
  • AssetMark first reported a position in Pediatrix Medical in Q4 2015 and has held it in 13 quarters since.
  • 253 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.